| Primary |
| Pulmonary Tuberculosis |
33.7% |
| Tuberculosis |
21.5% |
| Disseminated Tuberculosis |
19.0% |
| Immunosuppression |
8.0% |
| Hypertension |
6.1% |
| Meningitis Tuberculous |
4.9% |
| Bone Tuberculosis |
4.3% |
| Drug Therapy |
0.6% |
| Hyperuricaemia |
0.6% |
| Staphylococcal Infection |
0.6% |
| Tuberculosis Ureter |
0.6% |
|
| Acute Hepatic Failure |
16.7% |
| Hypertensive Encephalopathy |
8.3% |
| Jaundice |
8.3% |
| Multi-organ Failure |
6.3% |
| Renal Failure |
6.3% |
| Septic Shock |
6.3% |
| Hepatic Encephalopathy |
4.2% |
| Hepatitis |
4.2% |
| Hepatotoxicity |
4.2% |
| Immune Reconstitution Inflammatory Syndrome |
4.2% |
| Immune Reconstitution Syndrome |
4.2% |
| Liver Transplant |
4.2% |
| Pancreatitis |
4.2% |
| Sepsis |
4.2% |
| Weight Decreased |
4.2% |
| Alanine Aminotransferase Increased |
2.1% |
| Anaphylactic Reaction |
2.1% |
| Blood Bilirubin Increased |
2.1% |
| Blood Uric Acid Increased |
2.1% |
| Cough |
2.1% |
|
| Secondary |
| Tuberculosis |
35.8% |
| Pulmonary Tuberculosis |
27.9% |
| Hiv Infection |
7.4% |
| Disseminated Tuberculosis |
4.2% |
| Product Used For Unknown Indication |
4.0% |
| Tuberculosis Of Eye |
2.9% |
| Meningitis Tuberculous |
2.9% |
| Lymph Node Tuberculosis |
2.8% |
| Drug Use For Unknown Indication |
1.9% |
| Tuberculous Pleurisy |
1.7% |
| Prophylaxis |
1.4% |
| Rheumatoid Arthritis |
1.3% |
| Antiretroviral Therapy |
0.9% |
| Peritoneal Tuberculosis |
0.9% |
| Extrapulmonary Tuberculosis |
0.8% |
| Intermediate Uveitis |
0.8% |
| Hiv Test Positive |
0.7% |
| Tuberculosis Of Central Nervous System |
0.7% |
| Choroiditis |
0.6% |
| Retinal Vasculitis |
0.6% |
|
| Vomiting |
10.9% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
8.9% |
| Tuberculosis |
7.3% |
| Hepatitis |
5.9% |
| Hepatocellular Damage |
5.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.3% |
| Hepatotoxicity |
5.3% |
| Paradoxical Drug Reaction |
5.3% |
| Tuberculoma Of Central Nervous System |
5.3% |
| Pyrexia |
4.7% |
| Acute Hepatic Failure |
4.2% |
| Liver Disorder |
4.2% |
| Immune Reconstitution Syndrome |
3.6% |
| Jaundice |
3.6% |
| Toxic Epidermal Necrolysis |
3.6% |
| Weight Decreased |
3.6% |
| Renal Failure Acute |
3.4% |
| Rash Maculo-papular |
3.1% |
| Renal Failure |
3.1% |
| Deep Vein Thrombosis |
2.8% |
|
| Concomitant |
| Tuberculosis |
32.3% |
| Hiv Infection |
22.9% |
| Pulmonary Tuberculosis |
13.8% |
| Product Used For Unknown Indication |
7.7% |
| Drug Use For Unknown Indication |
6.6% |
| Lymph Node Tuberculosis |
1.8% |
| Meningitis Tuberculous |
1.7% |
| Pneumocystis Jiroveci Pneumonia |
1.5% |
| Antiretroviral Therapy |
1.3% |
| Disseminated Tuberculosis |
1.2% |
| Acquired Immunodeficiency Syndrome |
1.2% |
| Immunosuppression |
1.2% |
| Prophylaxis |
1.2% |
| Rheumatoid Arthritis |
1.1% |
| Antibiotic Prophylaxis |
1.1% |
| Hypertension |
0.8% |
| Oral Candidiasis |
0.8% |
| Bone Tuberculosis |
0.7% |
| Cardiac Failure |
0.7% |
| Ankylosing Spondylitis |
0.6% |
|
| Vomiting |
15.2% |
| Tuberculosis |
8.7% |
| Pyrexia |
7.8% |
| Weight Decreased |
6.6% |
| Immune Reconstitution Syndrome |
5.7% |
| Toxic Epidermal Necrolysis |
5.1% |
| Arrhythmia |
4.8% |
| Renal Failure |
4.8% |
| Renal Failure Acute |
4.5% |
| Hepatitis |
4.2% |
| Death |
3.9% |
| Psychotic Disorder |
3.9% |
| Pulmonary Tuberculosis |
3.9% |
| Vision Blurred |
3.6% |
| Drug Interaction |
3.3% |
| Hepatitis Toxic |
3.0% |
| Sepsis |
3.0% |
| Sudden Death |
3.0% |
| Neutropenia |
2.7% |
| Renal Impairment |
2.7% |
|
| Interacting |
| Tuberculosis |
27.3% |
| Disseminated Tuberculosis |
22.7% |
| Pulmonary Tuberculosis |
11.4% |
| Stem Cell Transplant |
9.1% |
| Hypertension |
4.5% |
| Renal Transplant |
4.5% |
| Pleurisy |
3.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.4% |
| Renal Cell Carcinoma Stage Iv |
3.4% |
| Hiv Infection |
2.3% |
| Hyperlipidaemia |
2.3% |
| Immunosuppression |
2.3% |
| Blood Uric Acid Increased |
1.1% |
| Grand Mal Convulsion |
1.1% |
| Prophylaxis |
1.1% |
|
| Tuberculosis |
18.8% |
| Drug Interaction |
12.5% |
| Hepatic Failure |
12.5% |
| Vomiting |
12.5% |
| Weight Decreased |
12.5% |
| Blood Alkaline Phosphatase Increased |
6.3% |
| Hepatitis B Surface Antigen Positive |
6.3% |
| Hepatocellular Injury |
6.3% |
| Hyperuricaemia |
6.3% |
| Thrombocytosis |
6.3% |
|
